Cargando…

N-terminal transactivation function, AF-1, of estrogen receptor alpha controls obesity through enhancement of energy expenditure

OBJECTIVE: Studies using the estrogen receptor alpha (ERα) knock-out (αERKO) mice have demonstrated that ERα plays a crucial role in various estrogen-mediated metabolic regulations. ERα is a ligand dependent transcription regulator and its activity is regulated by estrogenic compounds. ERα consists...

Descripción completa

Detalles Bibliográficos
Autores principales: Arao, Yukitomo, Hamilton, Katherine J., Lierz, Sydney L., Korach, Kenneth S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308972/
https://www.ncbi.nlm.nih.gov/pubmed/30287090
http://dx.doi.org/10.1016/j.molmet.2018.09.006
_version_ 1783383313814126592
author Arao, Yukitomo
Hamilton, Katherine J.
Lierz, Sydney L.
Korach, Kenneth S.
author_facet Arao, Yukitomo
Hamilton, Katherine J.
Lierz, Sydney L.
Korach, Kenneth S.
author_sort Arao, Yukitomo
collection PubMed
description OBJECTIVE: Studies using the estrogen receptor alpha (ERα) knock-out (αERKO) mice have demonstrated that ERα plays a crucial role in various estrogen-mediated metabolic regulations. ERα is a ligand dependent transcription regulator and its activity is regulated by estrogenic compounds. ERα consists of two transcriptional activation domains, AF-1 and AF-2. The activities of these domains are regulated through different mechanisms; however, the specific physiological role in metabolic regulation by these domains is still unclear. METHODS: We utilized an ERα AF-2 mutant knock-in mouse (AF2ERKI) to evaluate the physiological functionality of ERα transactivation domains. Due to the estrogen insensitive AF-2 mutation, the phenotypes of AF2ERKI mice are seemingly identical to the global αERKO including obesity in the females. Distinct from the αERKO, the AF-1 function of AF2ERKI mice can be activated by tamoxifen (Tam). Ovariectomized (OVX) AF2ERKI and WT females were treated with Tam and fed a high-fat diet (HFD) for 10 weeks. Additionally, indirect calorimetric analysis was performed using metabolic chambers with food intake and locomotor activity recorded for Tam-treated AF2ERKI and αERKO females. RESULTS: Obesity in HFD-fed AF2ERKI females was prevented by Tam treatment; particularly, inguinal fat accumulation was strongly blocked by Tam treatment. Alterations in fat metabolism genes, however, were not found in either inguinal fat nor visceral fat to be Tam-regulated, even though fat accumulation was strongly reduced by Tam treatment. Indirect calorimetric analysis revealed that without alteration of food intake and locomotor activity Tam treatment increased energy expenditure in AF2ERKI but not αERKO females. CONCLUSIONS: These results suggest that the activation of ERα AF-1 prevents fat accumulation. The prevention of obesity through AF-1 is mediated by induction of energy expenditure rather than ERα AF-1 functionality of lipid metabolism gene regulation in fat tissues.
format Online
Article
Text
id pubmed-6308972
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-63089722018-12-28 N-terminal transactivation function, AF-1, of estrogen receptor alpha controls obesity through enhancement of energy expenditure Arao, Yukitomo Hamilton, Katherine J. Lierz, Sydney L. Korach, Kenneth S. Mol Metab Original Article OBJECTIVE: Studies using the estrogen receptor alpha (ERα) knock-out (αERKO) mice have demonstrated that ERα plays a crucial role in various estrogen-mediated metabolic regulations. ERα is a ligand dependent transcription regulator and its activity is regulated by estrogenic compounds. ERα consists of two transcriptional activation domains, AF-1 and AF-2. The activities of these domains are regulated through different mechanisms; however, the specific physiological role in metabolic regulation by these domains is still unclear. METHODS: We utilized an ERα AF-2 mutant knock-in mouse (AF2ERKI) to evaluate the physiological functionality of ERα transactivation domains. Due to the estrogen insensitive AF-2 mutation, the phenotypes of AF2ERKI mice are seemingly identical to the global αERKO including obesity in the females. Distinct from the αERKO, the AF-1 function of AF2ERKI mice can be activated by tamoxifen (Tam). Ovariectomized (OVX) AF2ERKI and WT females were treated with Tam and fed a high-fat diet (HFD) for 10 weeks. Additionally, indirect calorimetric analysis was performed using metabolic chambers with food intake and locomotor activity recorded for Tam-treated AF2ERKI and αERKO females. RESULTS: Obesity in HFD-fed AF2ERKI females was prevented by Tam treatment; particularly, inguinal fat accumulation was strongly blocked by Tam treatment. Alterations in fat metabolism genes, however, were not found in either inguinal fat nor visceral fat to be Tam-regulated, even though fat accumulation was strongly reduced by Tam treatment. Indirect calorimetric analysis revealed that without alteration of food intake and locomotor activity Tam treatment increased energy expenditure in AF2ERKI but not αERKO females. CONCLUSIONS: These results suggest that the activation of ERα AF-1 prevents fat accumulation. The prevention of obesity through AF-1 is mediated by induction of energy expenditure rather than ERα AF-1 functionality of lipid metabolism gene regulation in fat tissues. Elsevier 2018-09-20 /pmc/articles/PMC6308972/ /pubmed/30287090 http://dx.doi.org/10.1016/j.molmet.2018.09.006 Text en http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Arao, Yukitomo
Hamilton, Katherine J.
Lierz, Sydney L.
Korach, Kenneth S.
N-terminal transactivation function, AF-1, of estrogen receptor alpha controls obesity through enhancement of energy expenditure
title N-terminal transactivation function, AF-1, of estrogen receptor alpha controls obesity through enhancement of energy expenditure
title_full N-terminal transactivation function, AF-1, of estrogen receptor alpha controls obesity through enhancement of energy expenditure
title_fullStr N-terminal transactivation function, AF-1, of estrogen receptor alpha controls obesity through enhancement of energy expenditure
title_full_unstemmed N-terminal transactivation function, AF-1, of estrogen receptor alpha controls obesity through enhancement of energy expenditure
title_short N-terminal transactivation function, AF-1, of estrogen receptor alpha controls obesity through enhancement of energy expenditure
title_sort n-terminal transactivation function, af-1, of estrogen receptor alpha controls obesity through enhancement of energy expenditure
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308972/
https://www.ncbi.nlm.nih.gov/pubmed/30287090
http://dx.doi.org/10.1016/j.molmet.2018.09.006
work_keys_str_mv AT araoyukitomo nterminaltransactivationfunctionaf1ofestrogenreceptoralphacontrolsobesitythroughenhancementofenergyexpenditure
AT hamiltonkatherinej nterminaltransactivationfunctionaf1ofestrogenreceptoralphacontrolsobesitythroughenhancementofenergyexpenditure
AT lierzsydneyl nterminaltransactivationfunctionaf1ofestrogenreceptoralphacontrolsobesitythroughenhancementofenergyexpenditure
AT korachkenneths nterminaltransactivationfunctionaf1ofestrogenreceptoralphacontrolsobesitythroughenhancementofenergyexpenditure